Therefore, we speculate that using adipocyte-specific NaKtide and HO-1 inducers should have a beneficial effect in COVID-19 patients by ameliorating oxidative stress, especially in those at higher risk due to increased baseline inflammation, such as diabetic and/or obese patients. Here, HMOX1 is linked to COVID-19.